(Q45856554)

17 December 2017

title

Evaluation of recombinant factor VIII (Kogenate) stability for continuous infusion using a minipump infusion device (English)

1 reference

17 December 2017

antihemophilic factor, human recombinant

main subject

1 reference

1

Hurst D

0 references

author name string

Zabor S

series ordinal

2

1 reference

17 December 2017

Malianni D

series ordinal

3

1 reference

17 December 2017

Miller D

series ordinal

4

1 reference

17 December 2017

publication date

1 November 1998

1 reference

17 December 2017

published in

Haemophilia

1 reference

17 December 2017

volume

4

1 reference

17 December 2017

issue

6

1 reference

17 December 2017

page(s)

785-789

1 reference

17 December 2017

Continuous intravenous infusion of factor VIII in classic haemophilia

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00204.X

Adjusted dose continuous infusion of factor VIII in patients with haemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00204.X

Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00204.X

The treatment of haemophilia, including prophylaxis, constant infusion and DDAVP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00204.X

Prophylaxis and therapy with factor VII concentrate (human) immuno, vapor heated in patients with congenital factor VII deficiency: a summary of case reports.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00204.X

Successful treatment of acute subdural haemorrhage with continuous intravenous infusion of factor VIII in a 17 year old with haemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00204.X

Continuous infusion of monoclonal antibody-purified factor VIII: rational approach to serious hemorrhage in patients with allo-/autoantibodies to factor VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00204.X

Comparison of continuous and intermittent Factor VIII concentrate therapy in hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00204.X

The use of continuous infusion of factor concentrates in the treatment of hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00204.X

Stability of factor VIII concentrates after reconstitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00204.X

Stability of factor VIII preparation in continuous infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00204.X

Coagulation factor concentrates by continuous infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00204.X

In vitro factor VIII recovery during the delivery of ultrapure factor VIII concentrate by continuous infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00204.X

10.1046/J.1365-2516.1998.00204.X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017